321 related articles for article (PubMed ID: 22337333)
1. Rodent models for human polycystic ovary syndrome.
Walters KA; Allan CM; Handelsman DJ
Biol Reprod; 2012 May; 86(5):149, 1-12. PubMed ID: 22337333
[TBL] [Abstract][Full Text] [Related]
2. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
3. Development of polycystic ovary syndrome: involvement of genetic and environmental factors.
Franks S; McCarthy MI; Hardy K
Int J Androl; 2006 Feb; 29(1):278-85; discussion 286-90. PubMed ID: 16390494
[TBL] [Abstract][Full Text] [Related]
4. Mouse models to study polycystic ovary syndrome: a possible link between metabolism and ovarian function?
van Houten EL; Visser JA
Reprod Biol; 2014 Mar; 14(1):32-43. PubMed ID: 24607253
[TBL] [Abstract][Full Text] [Related]
5. A unique rodent model of cardiometabolic risk associated with the metabolic syndrome and polycystic ovary syndrome.
Shi D; Dyck MK; Uwiera RR; Russell JC; Proctor SD; Vine DF
Endocrinology; 2009 Sep; 150(9):4425-36. PubMed ID: 19470707
[TBL] [Abstract][Full Text] [Related]
6. [The role of leptin in polycystic ovary syndrome].
Marciniak A; Starczewski A
Pol Merkur Lekarski; 2008 Oct; 25(148):390-3. PubMed ID: 19145943
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovary syndrome in adolescents.
Franks S
Int J Obes (Lond); 2008 Jul; 32(7):1035-41. PubMed ID: 18458678
[TBL] [Abstract][Full Text] [Related]
8. Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk.
Shi D; Vine DF
Fertil Steril; 2012 Jul; 98(1):185-93. PubMed ID: 22607890
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome in the Indian Subcontinent.
Allahbadia GN; Merchant R
Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited.
Kurzrock R; Cohen PR
Med Hypotheses; 2007; 68(3):480-3. PubMed ID: 17134841
[TBL] [Abstract][Full Text] [Related]
11. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E
Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003
[TBL] [Abstract][Full Text] [Related]
12. Acupuncture in polycystic ovary syndrome: current experimental and clinical evidence.
Stener-Victorin E; Jedel E; Mannerås L
J Neuroendocrinol; 2008 Mar; 20(3):290-8. PubMed ID: 18047551
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome--searching for an animal model.
Szukiewicz D; Uilenbroek JT
J Med; 1998; 29(5-6):259-75. PubMed ID: 10503163
[TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes and the polycystic ovary syndrome.
Pelusi B; Gambineri A; Pasquali R
Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
[TBL] [Abstract][Full Text] [Related]
15. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
Svendsen PF; Nilas L; Nørgaard K; Madsbad S
Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
Nardo LG; Patchava S; Laing I
Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
[TBL] [Abstract][Full Text] [Related]
17. Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review.
Paixão L; Ramos RB; Lavarda A; Morsh DM; Spritzer PM
Reprod Biol Endocrinol; 2017 Feb; 15(1):12. PubMed ID: 28183310
[TBL] [Abstract][Full Text] [Related]
18. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
19. Androgen levels and metabolic parameters are associated with a genetic variant of F13A1 in women with polycystic ovary syndrome.
Schweighofer N; Lerchbaum E; Trummer O; Schwetz V; Pilz S; Pieber TR; Obermayer-Pietsch B
Gene; 2012 Aug; 504(1):133-9. PubMed ID: 22565190
[TBL] [Abstract][Full Text] [Related]
20. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
